A detailed history of Dark Forest Capital Management LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Dark Forest Capital Management LP holds 12,834 shares of BMY stock, worth $755,537. This represents 0.09% of its overall portfolio holdings.

Number of Shares
12,834
Holding current value
$755,537
% of portfolio
0.09%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $508,996 - $664,159
12,834 New
12,834 $664,000
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $512,674 - $569,244
8,047 Added 879.45%
8,962 $573,000
Q1 2023

May 12, 2023

BUY
$65.71 - $74.53 $27,663 - $31,377
421 Added 85.22%
915 $63,000
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $33,829 - $40,058
494 New
494 $35,000
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $68,163 - $79,462
-1,271 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $75,205 - $88,093
1,271 New
1,271 $75,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.